Patient Guide: A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 28 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06450639
Status: 🟢 Enrolling Now
Condition: Duchenne Muscular Dystrophy
Phase: PHASE2

Where You Can Participate

This study is available at 28 locations across the country.

Top locations include:
  • • Little Rock, Arkansas
  • • Sacramento, California
  • • Atlanta, Georgia
  • • And 25 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD) - Join Clinical Trial NCTNCT06450639

How to Join This Clinical Trial - NCTNCT06450639

Learn how to participate in this PHASE2 trial studying an investigational therapy for Duchenne Muscular Dystrophy. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Duchenne Muscular Dystrophy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Duchenne Muscular Dystrophy
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06450639 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

Little Rock, Arkansas 72202 - United States

Status: RECRUITING

Clinical Research Site

Sacramento, California 95817 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Atlanta, Georgia 30329 - United States

Status: RECRUITING

Clinical Research Site

Worcester, Massachusetts 01655 - United States

Status: RECRUITING

Clinical Research Site

Grand Rapids, Michigan 49503 - United States

Status: RECRUITING

Clinical Research Site

Billings, Montana 59101 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

New York, New York 10032 - United States

Status: RECRUITING

Clinical Research Site

Denton, Texas 76208 - United States

Status: RECRUITING

Clinical Research Site

Norfolk, Virginia 23507 - United States

Status: RECRUITING

Clinical Research Site

Westmead, New South Wales 2145 - Australia

Status: NOT_YET_RECRUITING

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Duchenne Muscular Dystrophy:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships